Models | B (95% CI) | β | t | p | Adjusted R2 |
---|---|---|---|---|---|
SD | |||||
 Model 0: unadjusted | 0.086 (0.038–0.134) | 0.322 | 3.551 | 0.001 | 0.104 |
 Model 1: age, sex, BMI, WC, SBP, DBP and diabetes duration | 0.080 (0.031–0.129) | 0.300 | 3.231 | 0.002 | 0.145 |
 Model 2: Model 1  +  hypertension and glucose-lowering therapies | 0.060 (0.014–0.106) | 0.225 | 2.588 | 0.011 | 0.366 |
 Model 3: Model 2  +  eGFR, UA, lipid profiles, HbA1c, AUCglu, AUCcp and AUCgluca | 0.065 (0.003–0.128) | 0.251 | 2.112 | 0.041 | 0.678 |
CV | |||||
 Model 0: unadjusted | 0.838 (0.427–1.250) | 0.361 | 4.037 | < 0.001 | 0.130 |
 Model 1: age, sex, BMI, WC, SBP, DBP and diabetes duration | 0.810 (0.391–1.229) | 0.348 | 3.832 | < 0.001 | 0.179 |
 Model 2: Model 1  +  hypertension and glucose-lowering therapies | 0.676 (0.254–1.099) | 0.291 | 3.177 | 0.002 | 0.295 |
 Model 3: Model 2  +  eGFR, UA, lipid profiles, HbA1c, AUCglu, AUCcp and AUCgluca | 0.667 (0.055–1.279) | 0.286 | 2.207 | 0.033 | 0.618 |
MODD | |||||
 Model 0: unadjusted | 0.072 (0.030–0.115) | 0.308 | 3.381 | 0.001 | 0.095 |
 Model 1: age, sex, BMI, WC, SBP, DBP and diabetes duration | 0.065 (0.022–0.109) | 0.279 | 2.999 | 0.003 | 0.143 |
 Model 2: Model 1  +  hypertension and glucose-lowering therapies | 0.050 (0.009–0.091) | 0.213 | 2.402 | 0.018 | 0.342 |
 Model 3: Model 2  +  eGFR, UA, lipid profiles, HbA1c, AUCglu, AUCcp and AUCgluca | 0.041 (–0.019 to 0.100) | 0.188 | 1.374 | 0.177 | 0.575 |
MAGE | |||||
 Model 0: unadjusted | 0.150 (0.075–0.225) | 0.354 | 3.948 | < 0.001 | 0.125 |
 Model 1: age, sex, BMI, WC, SBP, DBP and diabetes duration | 0.138 (0.061–0.215) | 0.326 | 3.563 | 0.001 | 0.169 |
 Model 2: Model 1  +  hypertension and glucose-lowering therapies | 0.113 (0.038–0.187) | 0.266 | 3.004 | 0.003 | 0.342 |
 Model 3: Model 2  +  eGFR, UA, lipid profiles, HbA1c, AUCglu, AUCcp and AUCgluca | 0.135 (0.025–0.246) | 0.323 | 2.489 | 0.018 | 0.614 |
TIR3.9–10 | |||||
 Model 0: unadjusted | − 1.619 (− 2.353 to − 0.885) | − 0.386 | − 4.373 | < 0.001 | 0.149 |
 Model 1: age, sex, BMI, WC, SBP, DBP and diabetes duration | − 1.597 (− 2.345 to − 0.849) | − 0.381 | − 4.236 | < 0.001 | 0.196 |
 Model 2: Model 1  +  hypertension and glucose-lowering therapies | − 1.339 (− 2.076 to − 0.602) | − 0.319 | − 3.607 | < 0.001 | 0.347 |
 Model 3: Model 2  +  eGFR, UA, lipid Profiles, HbA1c, AUCglu, AUCcp and AUCgluca | − 1.701 (− 2.577 to − 0.825) | − 0.401 | − 3.930 | < 0.001 | 0.763 |